JD is a strong stock and might shoot up after ER, but just take extra caution there's a chance it might retest the support and continue at the bottom blue line and also watch out the RSI.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
